Tatva Chintan Pharma Chem Ltd. is launching its IPO. The Rs. 500 crore public offer comprises a fresh issue of equity shares aggregating up to Rs. 225 crores and an offer for sale of equity shares aggregating up to Rs. 275 crores.
Tatva Chintan Pharma Chem Ltd. is a speciality chemicals manufacturing company. It is the largest and only commercial manufacturer of structure-directing agents (SDAs) for zeolites in India, and also enjoys the second-largest position globally. Along with SDAs, the company is also engaged in the manufacture of phase transfer catalysts (PTCs), pharmaceutical and agrochemical intermediates, and other speciality chemicals which have applications across various industries such as the automotive, petroleum, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care and flavour and fragrances industries.
Apart from India, the company also exports its products to over 25 countries, including the USA, China, Germany, Japan, South Africa, and the UK. During the Fiscals ended March 31, 2021, exports of products amounted to 70.58% of the company’s revenue.
|Financial Year Ended||Revenue (₹ Crores)||PAT (₹ Crores)||EPS (₹)|
Issue Open Date : 16th July 2021 at 10 AM
Issue Close Date : 20th July 2021 at 5 PM
Price Band: Rs 1,073 to Rs 1,083
Lot Quantity: 13 shares per lot
For individual retail investor, you can not apply for less than 1 lot. You can set the bid price within the band.
Amount Needed: Rs 14,079 per lot (assuming you apply for 1 lot at Rs 1,083 bid price)
- You can apply for Tatva Chintan Pharma Chem IPO on IPO section within Niyo Money app. If you have not opened the Stocks & ETFs account already on Niyo Money, hurry up and open Stocks & ETFs account to access this feature.
- IPO application is a ASBA application using UPI mandate. You need to have an NPCI approved UPI handle which can process UPI mandate requests,
If you have the above things ready, you can apply for IPO on 16th July.
Disclosure: This is not a recommendation for subscribing to the IPO. The purpose is just to educate customers on the upcoming IPO.